The Food and Drugs Authority (FDA) has approved an investigational convalescent plasma collected from individuals who have recovered from COVID-19 for the treatment of critically ill COVID-19 patients.
The Presidential Advisor on Health, Dr Anthony Nsiah-Asare, who made this known on Tuesday, June 16, said the approval was given on Monday, June 15.
According to him, government through the Ghana Health Service (GHS) was working with all the key stakeholders including the COVID-19 Treatment Team, to ensure the success of this intervention.
What is convalescent plasma
Convalescent plasma (CP) is the term used for plasma that is removed from the blood of a person who has recovered from a disease, then transfused into a patient still battling it.